{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T02:32:01Z","timestamp":1785551521848,"version":"3.56.0"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T00:00:00Z","timestamp":1576713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["ZIC AR041169-12"],"award-info":[{"award-number":["ZIC AR041169-12"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["ZIC AR041181-11"],"award-info":[{"award-number":["ZIC AR041181-11"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["ZIC AR041207-04"],"award-info":[{"award-number":["ZIC AR041207-04"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["ZIG AR041168-12"],"award-info":[{"award-number":["ZIG AR041168-12"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["ZIH AR041173-12"],"award-info":[{"award-number":["ZIH AR041173-12"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["Project Code: 21311"],"award-info":[{"award-number":["Project Code: 21311"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003762","name":"Institut Pasteur","doi-asserted-by":"publisher","award":["PTR-113-17"],"award-info":[{"award-number":["PTR-113-17"]}],"id":[{"id":"10.13039\/501100003762","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.02972","type":"journal-article","created":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T04:29:30Z","timestamp":1576729770000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["JAK Inhibition Differentially Affects NK Cell and ILC1 Homeostasis"],"prefix":"10.3389","volume":"10","author":[{"given":"Laura","family":"Vian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mimi T.","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalia","family":"Gazaniga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Kieltyka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Pietropaolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Dell'Orso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen R.","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuko","family":"Furumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig J.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"O'Shea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Scium\u00e8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Gadina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,12,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.immuni.2008.03.002","article-title":"Cytokine signaling modules in inflammatory responses","volume":"28","author":"O'Shea","year":"2008","journal-title":"Immunity."},{"key":"B2","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/nrd.2017.201","article-title":"JAK inhibition as a therapeutic strategy for immune and inflammatory diseases","volume":"16","author":"Schwartz","year":"2017","journal-title":"Nat Rev Drug Discov."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.cell.2018.07.017","article-title":"Innate lymphoid cells: 10 years on","volume":"174","author":"Vivier","year":"2018","journal-title":"Cell."},{"key":"B4","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/ni.3482","article-title":"NK cells and type 1 innate lymphoid cells: partners in host defense","volume":"17","author":"Spits","year":"2016","journal-title":"Nat Immunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/nri3365","article-title":"Innate lymphoid cells-a proposal for uniform nomenclature","volume":"13","author":"Spits","year":"2013","journal-title":"Nat Rev Immunol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.smim.2014.01.010","article-title":"Tissue-resident natural killer cells and their potential diversity","volume":"26","author":"Sojka","year":"2014","journal-title":"Semin Immunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/eji.201747294","article-title":"ILC-poiesis: ensuring tissue ILC differentiation at the right place and time","volume":"49","author":"Lim","year":"2018","journal-title":"Eur J Immunol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1002\/eji.201747299","article-title":"T-bet and eomes govern differentiation and function of mouse and human NK cells and ILC1","volume":"48","author":"Zhang","year":"2018","journal-title":"Eur J Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3389\/fimmu.2017.00438","article-title":"HiJAKing innate lymphoid Cells?","volume":"8","author":"Scium\u00e8","year":"2017","journal-title":"Front Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"9852","DOI":"10.1073\/pnas.1610253113","article-title":"Network pharmacology of JAK inhibitors","volume":"113","author":"Moodley","year":"2016","journal-title":"Proc Natl Acad Sci USA."},{"key":"B11","first-page":"318","article-title":"The mechanism of action of tofacitinib-an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis","volume":"34","author":"Hodge","year":"2016","journal-title":"Clin Exp Rheumatol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1158\/0008-5472.CAN-14-3198","article-title":"JAK inhibition impairs NK cell function in myeloproliferative neoplasms","volume":"75","author":"Sch\u00f6nberg","year":"2015","journal-title":"Cancer Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12895-015-0025-y","article-title":"Effects of tofacitinib on lymphocyte sub-populations, CMV and EBV viral load in patients with plaque psoriasis","volume":"15","author":"Valenzuela","year":"2015","journal-title":"BMC Dermatol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/ni.1962","article-title":"The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling","volume":"12","author":"Spits","year":"2011","journal-title":"Nat Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/icb.2014.1","article-title":"The unconventional expression of IL-15 and its role in NK cell homeostasis","volume":"92","author":"Huntington","year":"2014","journal-title":"Immunol Cell Biol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.immuni.2019.03.028","article-title":"The \u03b3c family of cytokines: basic biology to therapeutic ramifications","volume":"50","author":"Leonard","year":"2019","journal-title":"Immunity."},{"key":"B17","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/imr.12705","article-title":"JAK\/STAT signaling in regulation of innate lymphoid cells: the gods before the guardians","volume":"286","author":"Stabile","year":"2018","journal-title":"Immunol Rev."},{"key":"B18","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/377065a0","article-title":"Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID)","volume":"377","author":"Macchi","year":"1995","journal-title":"Nature."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1038\/ni.3553","article-title":"Evidence of innate lymphoid cell redundancy in humans","volume":"17","author":"V\u00e9ly","year":"2016","journal-title":"Nat Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/mi.2017.38","article-title":"Jak3 deficiency blocks innate lymphoid cell development","volume":"11","author":"Robinette","year":"2018","journal-title":"Mucosal Immunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1073\/pnas.0507350103","article-title":"Stat5a\/b are essential for normal lymphoid development and differentiation","volume":"103","author":"Yao","year":"2006","journal-title":"Proc Natl Acad Sci USA."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1182\/blood-2010-06-291633","article-title":"A novel Ncr1-Cre mouse reveals the essential role of STAT5 for NK-cell survival and development","volume":"117","author":"Eckelhart","year":"2011","journal-title":"Blood."},{"key":"B23","doi-asserted-by":"publisher","first-page":"3108","DOI":"10.3389\/fimmu.2018.03108","article-title":"Loss of JAK1 drives innate immune deficiency","volume":"9","author":"Witalisz-Siepracka","year":"2018","journal-title":"Front Immunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1084\/jem.188.11.2067","article-title":"Stat5b is essential for natural killer cell-mediated proliferation and cytolytic activity","volume":"188","author":"Imada","year":"1998","journal-title":"J Exp Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1084\/jem.20150907","article-title":"Subset- and tissue-defined STAT5 thresholds control homeostasis and function of innate lymphoid cells","volume":"214","author":"Villarino","year":"2017","journal-title":"J Exp Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/JLB.5RI0218-084R","article-title":"Translational and clinical advances in JAK-STAT biology: the present and future of jakinibs","volume":"104","author":"Gadina","year":"2018","journal-title":"J Leukoc Biol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/art.39818","article-title":"Tofacitinib ameliorates murine lupus and its associated vascular dysfunction","volume":"69","author":"Furumoto","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.cell.2016.04.029","article-title":"Developmental acquisition of regulomes underlies innate lymphoid cell functionality","volume":"165","author":"Shih","year":"2016","journal-title":"Cell."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1021\/acschembio.9b00188","article-title":"PF-06651600, a Dual JAK3\/TEC family kinase inhibitor","volume":"14","author":"Xu","year":"2019","journal-title":"ACS Chem Biol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.chembiol.2011.01.012","article-title":"Jak1 has a dominant role over Jak3 in signal transduction through \u03b3c-containing cytokine receptors","volume":"18","author":"Haan","year":"2011","journal-title":"Chem Biol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1038\/ni.2395","article-title":"Immunological Genome Project Consortium. Molecular definition of the identity and activation of natural killer cells","volume":"13","author":"Bezman","year":"2012","journal-title":"Nat Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"5488","DOI":"10.1182\/blood-2008-10-187179","article-title":"Maturation of mouse NK cells is a 4-stage developmental program","volume":"113","author":"Chiossone","year":"2009","journal-title":"Blood."},{"key":"B33","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.immuni.2018.09.009","article-title":"High-dimensional single-cell analysis identifies organ-specific signatures and conserved NK cell subsets in humans and mice","volume":"49","author":"Crinier","year":"2018","journal-title":"Immunity."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1038\/ni.3248","article-title":"TCF-1 upregulation identifies early innate lymphoid progenitors in the bone marrow","volume":"16","author":"Yang","year":"2015","journal-title":"Nat Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1038\/ni1487","article-title":"Interleukin 15-mediated survival of natural killer cells is determined by interactions among Bim, Noxa and Mcl-1","volume":"8","author":"Huntington","year":"2007","journal-title":"Nat Immunol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"4539","DOI":"10.1038\/ncomms5539","article-title":"Innate immunodeficiency following genetic ablation of Mcl1 in natural killer cells","volume":"5","author":"Sathe","year":"2014","journal-title":"Nat Commun."},{"key":"B37","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1084\/jem.20160869","article-title":"Cell cycle progression dictates the requirement for BCL2 in natural killer cell survival","volume":"214","author":"Viant","year":"2017","journal-title":"J Exp Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1038\/s41467-017-01477-5","article-title":"Critical functions for STAT5 tetramers in the maturation and survival of natural killer cells","volume":"8","author":"Lin","year":"2017","journal-title":"Nat Commun."},{"key":"B39","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1158\/2159-8290.CD-15-0732","article-title":"STAT5 Is a key regulator in NK cells and acts as a molecular switch from tumor surveillance to tumor promotion","volume":"6","author":"Gotthardt","year":"2016","journal-title":"Cancer Discov."},{"key":"B40","doi-asserted-by":"publisher","first-page":"3885","DOI":"10.1158\/0008-5472.CAN-17-0082","article-title":"Venetoclax synergizes with radiotherapy for treatment of B-cell lymphomas","volume":"77","author":"O'Steen","year":"2017","journal-title":"Cancer Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1158\/1078-0432.CCR-17-1606","article-title":"Venetoclax is effective in small-cell lung cancers with high BCL-2 expression","volume":"24","author":"Lochmann","year":"2018","journal-title":"Clin Cancer Res."},{"key":"B42","doi-asserted-by":"publisher","first-page":"3626","DOI":"10.1182\/blood-2007-08-106203","article-title":"CCL3 and CXCL12 regulate trafficking of mouse bone marrow NK cell subsets","volume":"111","author":"Bernardini","year":"2008","journal-title":"Blood."},{"key":"B43","doi-asserted-by":"publisher","first-page":"4863","DOI":"10.1182\/blood-2011-06-362574","article-title":"Sequential desensitization of CXCR4 and S1P5 controls natural killer cell trafficking","volume":"118","author":"Mayol","year":"2011","journal-title":"Blood."},{"key":"B44","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.immuni.2019.06.001","article-title":"Characterization of transcriptional regulatory networks that promote and restrict identities and functions of intestinal innate lymphoid cells","volume":"51","author":"Pokrovskii","year":"2019","journal-title":"Immunity."},{"key":"B45","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/ni.3470","article-title":"CIS is a potent checkpoint in NK cell-mediated tumor immunity","volume":"17","author":"Delconte","year":"2016","journal-title":"Nat Immunol."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.02972\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T04:29:35Z","timestamp":1576729775000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.02972\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,19]]},"references-count":45,"alternative-id":["10.3389\/fimmu.2019.02972"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.02972","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,19]]},"article-number":"2972"}}